NL8900574A - Antivirale en immunostimulerende farmaceutische preparaten en werkwijze voor de bereiding ervan. - Google Patents

Antivirale en immunostimulerende farmaceutische preparaten en werkwijze voor de bereiding ervan. Download PDF

Info

Publication number
NL8900574A
NL8900574A NL8900574A NL8900574A NL8900574A NL 8900574 A NL8900574 A NL 8900574A NL 8900574 A NL8900574 A NL 8900574A NL 8900574 A NL8900574 A NL 8900574A NL 8900574 A NL8900574 A NL 8900574A
Authority
NL
Netherlands
Prior art keywords
acid
preparation
lysine
active ingredients
fatty acids
Prior art date
Application number
NL8900574A
Other languages
English (en)
Dutch (nl)
Original Assignee
Biorex Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kft filed Critical Biorex Kft
Publication of NL8900574A publication Critical patent/NL8900574A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL8900574A 1988-03-09 1989-03-09 Antivirale en immunostimulerende farmaceutische preparaten en werkwijze voor de bereiding ervan. NL8900574A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU881132A HU209973B (en) 1988-03-09 1988-03-09 Process for production of antiviral and immunstimular pharmaceutical composition
HU113288 1988-03-09

Publications (1)

Publication Number Publication Date
NL8900574A true NL8900574A (nl) 1989-10-02

Family

ID=10952974

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8900574A NL8900574A (nl) 1988-03-09 1989-03-09 Antivirale en immunostimulerende farmaceutische preparaten en werkwijze voor de bereiding ervan.

Country Status (14)

Country Link
JP (1) JPH01316316A (xx)
KR (1) KR890014103A (xx)
BE (1) BE1002890A3 (xx)
CA (1) CA1334576C (xx)
CH (1) CH678918A5 (xx)
DE (1) DE3907649C2 (xx)
FI (1) FI94591C (xx)
FR (1) FR2628324B1 (xx)
GB (1) GB2216418B (xx)
HU (1) HU209973B (xx)
IT (1) IT1229562B (xx)
LU (1) LU87471A1 (xx)
NL (1) NL8900574A (xx)
SE (1) SE8900828L (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210122B (en) * 1988-03-23 1995-02-28 Biorex Kutato Fejlesztoe Kft Process for production of composition against thromboembolytic conditions of circulating system and heart
JPH04279523A (ja) * 1991-01-11 1992-10-05 Nisshin Flour Milling Co Ltd 免疫賦活油脂加工品
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
CA2159116A1 (en) * 1993-03-26 1994-10-13 Constantin Romulus Dinu Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5767156A (en) * 1993-10-06 1998-06-16 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
AUPM906594A0 (en) * 1994-10-26 1994-11-17 Peptide Technology Limited Synthetic polyunsaturated fatty acid analogues
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
US5639858A (en) * 1995-03-22 1997-06-17 Tularik, Inc. Human signal transducer and binding assays
WO1996030381A1 (en) * 1995-03-28 1996-10-03 Novo Nordisk A/S Immunosuppressive agents
HU227588B1 (hu) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
BRPI0820802A2 (pt) * 2007-12-17 2015-06-16 Univ Florida Materiais e métodos para tratamento de proliferação vascular ocular patológica
FR3031451B1 (fr) * 2015-01-13 2018-03-23 Greentech Sel d'un triglyceride, preparation et utilisations
EP3248467A1 (de) 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
EP3463310B1 (en) * 2016-05-25 2023-07-05 Evonik Operations GmbH Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
WO2019008101A1 (en) 2017-07-06 2019-01-10 Evonik Technochemie Gmbh ENTERICALLY COATED SOLID DOSAGE FORM COMPRISING AMINO ACIDS SALTS OF OMEGA-3 FATTY ACIDS
KR102628351B1 (ko) 2017-08-15 2024-01-25 에보니크 오퍼레이션즈 게엠베하 오메가-3 지방산 아미노산 염의 높은 활성 성분 함량을 갖는 정제
MX2022001570A (es) 2019-08-08 2022-03-02 Evonik Operations Gmbh Proceso de flujo descendente para la produccion de sales de acidos grasos poliinsaturados.
US20220287345A1 (en) 2019-08-08 2022-09-15 Evonik Operations Gmbh Solubility enhancement of poorly soluble actives
DE102022003441A1 (de) 2022-09-17 2024-03-28 Jutta Ibrahim Nahrungsergänzungsmittel Omega3 und essentielle Aminosäure(n)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256162A (en) * 1968-08-16 1971-12-08 Braun Fa B Improvements in and relating to liquid products for intravenous administration
FR2215212B1 (xx) * 1973-01-18 1976-03-05 Seperic Ch
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
GB2118437B (en) * 1982-03-01 1984-12-12 Efamol Ltd Composition for treating alcoholism
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
DE3229956A1 (de) * 1982-08-12 1984-02-16 Erichsen, Friedrich Karl, Dr., 2351 Schillsdorf Arzneimittel mit cytostatischer wirkung
DE3514328C1 (de) * 1985-04-19 1986-09-11 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, 6900 Heidelberg Verwendung von L-Ornithin bei der selektiven Hemmung von cytotoxischen T-Lymphozyten-Effektorzellen
ATE88631T1 (de) * 1986-09-17 1993-05-15 Clintec Nutrition Co Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
DE3878812T2 (de) * 1987-02-20 1993-07-22 Shriners Hospitals For Cripple Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.
DE3726299A1 (de) * 1987-06-26 1989-02-23 Dietl Hans Fettemulsion zur intravenoesen anwendung

Also Published As

Publication number Publication date
FR2628324B1 (fr) 1994-05-27
SE8900828L (sv) 1989-09-10
GB2216418B (en) 1991-12-11
SE8900828D0 (sv) 1989-03-09
LU87471A1 (fr) 1990-10-02
IT8919704A0 (it) 1989-03-09
GB8905385D0 (en) 1989-04-19
GB2216418A (en) 1989-10-11
BE1002890A3 (fr) 1991-07-16
HUT60432A (en) 1992-09-28
FI94591C (fi) 1995-10-10
FI94591B (fi) 1995-06-30
IT1229562B (it) 1991-09-04
JPH01316316A (ja) 1989-12-21
DE3907649A1 (de) 1989-09-28
HU209973B (en) 1995-01-30
KR890014103A (ko) 1989-10-21
FI891145A (fi) 1989-09-10
FI891145A0 (fi) 1989-03-09
FR2628324A1 (fr) 1989-09-15
CH678918A5 (xx) 1991-11-29
CA1334576C (en) 1995-02-28
DE3907649C2 (de) 1996-07-11

Similar Documents

Publication Publication Date Title
NL8900574A (nl) Antivirale en immunostimulerende farmaceutische preparaten en werkwijze voor de bereiding ervan.
Blinkova et al. Biological activity of Spirulina Zh Mikrobiol Epidemiol Immunobiol. 2001 Mar-Apr;(2): 114–8. Review. In this review information of Spirulina platensis (SP), a blue-green alga (photosynthesizing cyanobacterium) having diverse biological activity is presented. Due to high content of highly
RAICA JR et al. Blood cell transaminase activity in human vitamin B6deficiency
Junquero et al. Inhibition of cytokine‐induced nitric oxide production by transforming growth factor‐beta 1 in human smooth muscle cells.
NL8900573A (nl) Nieuwe zout-type verbindingen, farmaceutische preparaten met dergelijke verbindingen erin en werkwijze voor de bereiding ervan.
CS251060B2 (en) 9-(hydroxyalkyl)purines' derivatives salts production method
Suzuki et al. Studies on antiviral agents. IV. Biological activity of tenuazonic acid derivatives.
US5824664A (en) Suppression of HIV expression by organic thiophosphate
Elmore et al. Kinetics and mechanism of catalysis by proteolytic enzymes: The kinetics of hydrolysis of derivatives of l-lysine and S-(β-aminoethyl)-l-cysteine (thialysine) by bovine trypsin
Sacklin et al. Effect of DDT on enzymatic oxidation and phosphorylation
US5543300A (en) Method and composition for determining the immunological activity of bioactive substances
Hughes-Fulford et al. Effects of dimethyl prostaglandin A1 on herpes simplex virus and human immunodeficiency virus replication
KR0128098B1 (ko) 항hiv제
Segel et al. Amino acid transport in human lymphocytes: distinctions in the enhanced uptake with PHA treatment or amino acid deprivation
Gupta et al. Amino acid transport by the filamentous fungus Arthrobotrys conoides
Schales Effect of additions to ACD blood on erythrocyte preservation.
Borg et al. A colorimetric assay for the assessment of cytotoxicity of yeasts
IT9048102A1 (it) Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
CA2176392C (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
US6140367A (en) Use of ethylene diamine disuccinate for preparing a medicament with antiviral properties
Verini et al. Antiviral activity of a pyrazino-pyrazine derivative
JPH04330095A (ja) 生理活性ポリペプチド、その製造法および抗菌剤
Porzsolt et al. Measurement of Cell Mediated Cytotoxicity by Post‐Labeling Surviving Target Cells
Syeklocha Biological activities of an antiviral substance from Penicillium cyaneo-fulvum.
Borsook et al. A Convenient Quick Method of Obtaining Vitamin B12 Concentrate

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed